Global Neonatal Respiratory Distress Syndrome Treatment Market Growth (Status and Outlook) 2026-2032
The global Neonatal Respiratory Distress Syndrome Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Neonatal Respiratory Distress Syndrome Treatment Industry Forecast” looks at past sales and reviews total world Neonatal Respiratory Distress Syndrome Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Neonatal Respiratory Distress Syndrome Treatment sales for 2026 through 2032. With Neonatal Respiratory Distress Syndrome Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neonatal Respiratory Distress Syndrome Treatment industry.
This Insight Report provides a comprehensive analysis of the global Neonatal Respiratory Distress Syndrome Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neonatal Respiratory Distress Syndrome Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neonatal Respiratory Distress Syndrome Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neonatal Respiratory Distress Syndrome Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neonatal Respiratory Distress Syndrome Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Neonatal Respiratory Distress Syndrome Treatment market by product type, application, key players and key regions and countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Neonatal Respiratory Distress Syndrome Treatment Industry Forecast” looks at past sales and reviews total world Neonatal Respiratory Distress Syndrome Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Neonatal Respiratory Distress Syndrome Treatment sales for 2026 through 2032. With Neonatal Respiratory Distress Syndrome Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neonatal Respiratory Distress Syndrome Treatment industry.
This Insight Report provides a comprehensive analysis of the global Neonatal Respiratory Distress Syndrome Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neonatal Respiratory Distress Syndrome Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neonatal Respiratory Distress Syndrome Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neonatal Respiratory Distress Syndrome Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neonatal Respiratory Distress Syndrome Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Neonatal Respiratory Distress Syndrome Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oxygen Therapy
- Surfactant Therapy
- Others
Segmentation by Application:
- Hospitals
- Home Care
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Dragerwerk
- GE HealthCare
- Koninklijke Philips
- Smiths Medical
- Fisher & Paykel Healthcare
- IBIO
- Windtree Therapeutics
- Synthetic Biologics
- Synairgen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size (2021-2032)
2.1.2 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neonatal Respiratory Distress Syndrome Treatment by Country/Region (2021, 2025 & 2032)
2.2 Neonatal Respiratory Distress Syndrome Treatment Segment by Type
2.2.1 Oxygen Therapy
2.2.2 Surfactant Therapy
2.2.3 Others
2.2.4 Neonatal Respiratory Distress Syndrome Treatment Market Size by Type
2.2.4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
2.3 Neonatal Respiratory Distress Syndrome Treatment Segment by Application
2.3.1 Hospitals
2.3.2 Home Care
2.3.3 Others
2.3.4 Neonatal Respiratory Distress Syndrome Treatment Market Size by Application
2.3.4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
3 NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT MARKET SIZE BY PLAYER
3.1 Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Player
3.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2021-2026)
3.1.2 Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT BY REGION
4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026)
4.2 Global Neonatal Respiratory Distress Syndrome Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.4 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.5 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026)
5.2 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
5.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026)
6.2 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
6.3 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026)
7.2 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
7.3 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment by Region (2021-2026)
8.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT MARKET FORECAST
10.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.1.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.2 Canada Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.3 Mexico Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.4 Brazil Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.3.1 China Neonatal Respiratory Distress Syndrome Treatment Market Forecast
10.3.2 Japan Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.3 Korea Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.4 Southeast Asia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.5 India Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.6 Australia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.2 France Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.3 UK Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.4 Italy Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.5 Russia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.2 South Africa Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.3 Israel Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.4 Turkey Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.6 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Type (2027-2032)
10.7 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neonatal Respiratory Distress Syndrome Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Dragerwerk
11.2.1 Dragerwerk Company Information
11.2.2 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dragerwerk Main Business Overview
11.2.5 Dragerwerk Latest Developments
11.3 GE HealthCare
11.3.1 GE HealthCare Company Information
11.3.2 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GE HealthCare Main Business Overview
11.3.5 GE HealthCare Latest Developments
11.4 Koninklijke Philips
11.4.1 Koninklijke Philips Company Information
11.4.2 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Koninklijke Philips Main Business Overview
11.4.5 Koninklijke Philips Latest Developments
11.5 Smiths Medical
11.5.1 Smiths Medical Company Information
11.5.2 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Smiths Medical Main Business Overview
11.5.5 Smiths Medical Latest Developments
11.6 Fisher & Paykel Healthcare
11.6.1 Fisher & Paykel Healthcare Company Information
11.6.2 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fisher & Paykel Healthcare Main Business Overview
11.6.5 Fisher & Paykel Healthcare Latest Developments
11.7 IBIO
11.7.1 IBIO Company Information
11.7.2 IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 IBIO Main Business Overview
11.7.5 IBIO Latest Developments
11.8 Windtree Therapeutics
11.8.1 Windtree Therapeutics Company Information
11.8.2 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Windtree Therapeutics Main Business Overview
11.8.5 Windtree Therapeutics Latest Developments
11.9 Synthetic Biologics
11.9.1 Synthetic Biologics Company Information
11.9.2 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Synthetic Biologics Main Business Overview
11.9.5 Synthetic Biologics Latest Developments
11.10 Synairgen
11.10.1 Synairgen Company Information
11.10.2 Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Synairgen Main Business Overview
11.10.5 Synairgen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size (2021-2032)
2.1.2 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neonatal Respiratory Distress Syndrome Treatment by Country/Region (2021, 2025 & 2032)
2.2 Neonatal Respiratory Distress Syndrome Treatment Segment by Type
2.2.1 Oxygen Therapy
2.2.2 Surfactant Therapy
2.2.3 Others
2.2.4 Neonatal Respiratory Distress Syndrome Treatment Market Size by Type
2.2.4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
2.3 Neonatal Respiratory Distress Syndrome Treatment Segment by Application
2.3.1 Hospitals
2.3.2 Home Care
2.3.3 Others
2.3.4 Neonatal Respiratory Distress Syndrome Treatment Market Size by Application
2.3.4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
3 NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT MARKET SIZE BY PLAYER
3.1 Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Player
3.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2021-2026)
3.1.2 Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT BY REGION
4.1 Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026)
4.2 Global Neonatal Respiratory Distress Syndrome Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.4 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.5 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026)
5.2 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
5.3 Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026)
6.2 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
6.3 APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026)
7.2 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
7.3 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment by Region (2021-2026)
8.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT MARKET FORECAST
10.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.1.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast
10.1.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2 Americas Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.2 Canada Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.3 Mexico Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.2.4 Brazil Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3 APAC Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.3.1 China Neonatal Respiratory Distress Syndrome Treatment Market Forecast
10.3.2 Japan Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.3 Korea Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.4 Southeast Asia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.5 India Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.3.6 Australia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4 Europe Neonatal Respiratory Distress Syndrome Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.2 France Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.3 UK Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.4 Italy Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.4.5 Russia Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.2 South Africa Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.3 Israel Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.5.4 Turkey Market Neonatal Respiratory Distress Syndrome Treatment Forecast
10.6 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Type (2027-2032)
10.7 Global Neonatal Respiratory Distress Syndrome Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neonatal Respiratory Distress Syndrome Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Dragerwerk
11.2.1 Dragerwerk Company Information
11.2.2 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dragerwerk Main Business Overview
11.2.5 Dragerwerk Latest Developments
11.3 GE HealthCare
11.3.1 GE HealthCare Company Information
11.3.2 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GE HealthCare Main Business Overview
11.3.5 GE HealthCare Latest Developments
11.4 Koninklijke Philips
11.4.1 Koninklijke Philips Company Information
11.4.2 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Koninklijke Philips Main Business Overview
11.4.5 Koninklijke Philips Latest Developments
11.5 Smiths Medical
11.5.1 Smiths Medical Company Information
11.5.2 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Smiths Medical Main Business Overview
11.5.5 Smiths Medical Latest Developments
11.6 Fisher & Paykel Healthcare
11.6.1 Fisher & Paykel Healthcare Company Information
11.6.2 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fisher & Paykel Healthcare Main Business Overview
11.6.5 Fisher & Paykel Healthcare Latest Developments
11.7 IBIO
11.7.1 IBIO Company Information
11.7.2 IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 IBIO Main Business Overview
11.7.5 IBIO Latest Developments
11.8 Windtree Therapeutics
11.8.1 Windtree Therapeutics Company Information
11.8.2 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Windtree Therapeutics Main Business Overview
11.8.5 Windtree Therapeutics Latest Developments
11.9 Synthetic Biologics
11.9.1 Synthetic Biologics Company Information
11.9.2 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Synthetic Biologics Main Business Overview
11.9.5 Synthetic Biologics Latest Developments
11.10 Synairgen
11.10.1 Synairgen Company Information
11.10.2 Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered
11.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Synairgen Main Business Overview
11.10.5 Synairgen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neonatal Respiratory Distress Syndrome Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oxygen Therapy
Table 4. Major Players of Surfactant Therapy
Table 5. Major Players of Others
Table 6. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Table 9. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Table 12. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2021-2026)
Table 14. Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered
Table 15. Neonatal Respiratory Distress Syndrome Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Table 20. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2021-2026)
Table 24. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Table 26. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Table 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Table 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2021-2026)
Table 34. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Neonatal Respiratory Distress Syndrome Treatment
Table 40. Key Market Challenges & Risks of Neonatal Respiratory Distress Syndrome Treatment
Table 41. Key Industry Trends of Neonatal Respiratory Distress Syndrome Treatment
Table 42. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Medtronic Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 47. Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 48. Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Medtronic Main Business
Table 50. Medtronic Latest Developments
Table 51. Dragerwerk Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 52. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 53. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Dragerwerk Main Business
Table 55. Dragerwerk Latest Developments
Table 56. GE HealthCare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 57. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 58. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. GE HealthCare Main Business
Table 60. GE HealthCare Latest Developments
Table 61. Koninklijke Philips Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 62. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 63. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Koninklijke Philips Main Business
Table 65. Koninklijke Philips Latest Developments
Table 66. Smiths Medical Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 67. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 68. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Smiths Medical Main Business
Table 70. Smiths Medical Latest Developments
Table 71. Fisher & Paykel Healthcare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 72. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 73. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fisher & Paykel Healthcare Main Business
Table 75. Fisher & Paykel Healthcare Latest Developments
Table 76. IBIO Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 77. IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 78. IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. IBIO Main Business
Table 80. IBIO Latest Developments
Table 81. Windtree Therapeutics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 82. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 83. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Windtree Therapeutics Main Business
Table 85. Windtree Therapeutics Latest Developments
Table 86. Synthetic Biologics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 87. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 88. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Synthetic Biologics Main Business
Table 90. Synthetic Biologics Latest Developments
Table 91. Synairgen Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 92. Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 93. Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Synairgen Main Business
Table 95. Synairgen Latest Developments
Table 1. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neonatal Respiratory Distress Syndrome Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oxygen Therapy
Table 4. Major Players of Surfactant Therapy
Table 5. Major Players of Others
Table 6. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Table 9. Neonatal Respiratory Distress Syndrome Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Table 12. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player (2021-2026)
Table 14. Neonatal Respiratory Distress Syndrome Treatment Key Players Head office and Products Offered
Table 15. Neonatal Respiratory Distress Syndrome Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Table 20. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2021-2026)
Table 24. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Table 26. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Table 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Table 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country (2021-2026)
Table 34. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Neonatal Respiratory Distress Syndrome Treatment
Table 40. Key Market Challenges & Risks of Neonatal Respiratory Distress Syndrome Treatment
Table 41. Key Industry Trends of Neonatal Respiratory Distress Syndrome Treatment
Table 42. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Medtronic Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 47. Medtronic Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 48. Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Medtronic Main Business
Table 50. Medtronic Latest Developments
Table 51. Dragerwerk Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 52. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 53. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Dragerwerk Main Business
Table 55. Dragerwerk Latest Developments
Table 56. GE HealthCare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 57. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 58. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. GE HealthCare Main Business
Table 60. GE HealthCare Latest Developments
Table 61. Koninklijke Philips Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 62. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 63. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Koninklijke Philips Main Business
Table 65. Koninklijke Philips Latest Developments
Table 66. Smiths Medical Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 67. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 68. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Smiths Medical Main Business
Table 70. Smiths Medical Latest Developments
Table 71. Fisher & Paykel Healthcare Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 72. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 73. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fisher & Paykel Healthcare Main Business
Table 75. Fisher & Paykel Healthcare Latest Developments
Table 76. IBIO Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 77. IBIO Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 78. IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. IBIO Main Business
Table 80. IBIO Latest Developments
Table 81. Windtree Therapeutics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 82. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 83. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Windtree Therapeutics Main Business
Table 85. Windtree Therapeutics Latest Developments
Table 86. Synthetic Biologics Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 87. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 88. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Synthetic Biologics Main Business
Table 90. Synthetic Biologics Latest Developments
Table 91. Synairgen Details, Company Type, Neonatal Respiratory Distress Syndrome Treatment Area Served and Its Competitors
Table 92. Synairgen Neonatal Respiratory Distress Syndrome Treatment Product Offered
Table 93. Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Synairgen Main Business
Table 95. Synairgen Latest Developments
LIST OF FIGURES
Figure 1. Neonatal Respiratory Distress Syndrome Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neonatal Respiratory Distress Syndrome Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2025)
Figure 8. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type in 2025
Figure 10. Neonatal Respiratory Distress Syndrome Treatment in Hospitals
Figure 11. Global Neonatal Respiratory Distress Syndrome Treatment Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Neonatal Respiratory Distress Syndrome Treatment in Home Care
Figure 13. Global Neonatal Respiratory Distress Syndrome Treatment Market: Home Care (2021-2026) & ($ millions)
Figure 14. Neonatal Respiratory Distress Syndrome Treatment in Others
Figure 15. Global Neonatal Respiratory Distress Syndrome Treatment Market: Others (2021-2026) & ($ millions)
Figure 16. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application in 2025
Figure 17. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player in 2025
Figure 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Neonatal Respiratory Distress Syndrome Treatment Value Market Share by Country in 2025
Figure 24. United States Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 1. Neonatal Respiratory Distress Syndrome Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neonatal Respiratory Distress Syndrome Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2025)
Figure 8. Neonatal Respiratory Distress Syndrome Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type in 2025
Figure 10. Neonatal Respiratory Distress Syndrome Treatment in Hospitals
Figure 11. Global Neonatal Respiratory Distress Syndrome Treatment Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Neonatal Respiratory Distress Syndrome Treatment in Home Care
Figure 13. Global Neonatal Respiratory Distress Syndrome Treatment Market: Home Care (2021-2026) & ($ millions)
Figure 14. Neonatal Respiratory Distress Syndrome Treatment in Others
Figure 15. Global Neonatal Respiratory Distress Syndrome Treatment Market: Others (2021-2026) & ($ millions)
Figure 16. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application in 2025
Figure 17. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Player in 2025
Figure 18. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Neonatal Respiratory Distress Syndrome Treatment Value Market Share by Country in 2025
Figure 24. United States Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Neonatal Respiratory Distress Syndrome Treatment Market Size 2027-2032 ($ millions)
